education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. The hematology/oncology residency is a one-year ASHP-accredited specialty residency at the South Texas Veterans Healthcare Administration. Oncology Postgraduate Year Two (PGY2) Purpose. Accreditation Standards - PGY2 Pharmacy Residencies. Starting a Residency. The PGY2 Oncology Pharmacy Residency is an American Society of Health System Pharmacists (ASHP) accredited residency program. PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) Accreditation Standards - PGY1 Pharmacy Residencies. PGY2 Accreditation Standards and CAGOs . PGY1 Accreditation Standards and CAGOs . Search the ASHP Residency Directory for accredited IPPR, PGY1, PGY2 and PGY1 & PGY2 Combined programs within the United States. Program Structure The PGY2 Oncology Residency is a full-time, one-year commitment, typically beginning on July 1 st and ending on June 30 th . This is accomplished through core rotations to strengthen hematology and oncology fundamentals as well as elective rotations with the flexibility to meet the individual's needs. The UC Davis Health PGY2 Oncology Residency is designed to meet the educational goals and objectives, as outlined by the ASHP PGY2 Oncology Residency Accreditation Standard. The ASHP Accreditation Standard for Postgraduate Year One (PGY1) Pharmacy Residency Programs establishes criteria for residency programs building upon Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for … PGY1 Competency Areas, Goals and Objectives. • Orientation to PGY2 Oncology Pharmacy Residency • Inpatient Hematology Hematology/Oncology • Inpatient Blood & Marrow Transplant ... • Support to attend one national peer meeting (ie ASHP Midyear Clinical Meeting, ACCP, ASCO, HOPA) UW HEALTH INFO: The purpose of a PGY2 Oncology residency is to develop specialized knowledge into the pathophysiology and management of patients with hematology and oncology disorders. Major areas of clinical involvement and training are in malignant and benign hematology, medical oncology, blood and marrow transplantation, supportive care and prevention or management of antineoplastic and immunotherapy toxicity. PGY2 Program Description The oncology pharmacy residency program is a 12-month period of education and experiences that focuses on oncology pharmacy practice and is designed to provide ongoing pharmacy clinical activities while promoting the Starting a Residency Program. The goal of the PGY-2 Hematology/Oncology Residency Program is to provide a broad experience-based foundation in hematology/oncology, to develop his/her clinical skills, and to prepare for a comprehensive clinical practice in hematology/oncology. PGY2 Competency Areas, Goals and Objectives. PGY2 residents receive training in hematologic and solid cancers, symptom management, oncology pharmacy administration, and investigational therapeutics at the UCSF Helen Diller Family Comprehensive Cancer Center. ... and its goals and learning objectives are consistent with standards developed by ASHP. The purpose of the PGY2 Oncology Pharmacy Residency Program at BronxCare Health System is to train residents to become competent clinicians managing oncology/hematology patients in an ever evolving and advancing chemotherapy.